You are here: Home News & Publications News & Publications Recent news and updates from Evox Evox Therapeutics expands existing exosome patent portfolio with further grant covering exosomes for RNA therapeutics 15th Jul 2020 Evox Therapeutics announces a multi-target RNA interference and antisense research collaboration and license agreement with Lilly 9th Jun 2020 Evox Therapeutics appoints Martin Andrews as Non-Executive Director 27th May 2020 Evox Therapeutics appoints Dr Sonya Montgomery as Chief Medical Officer 19th May 2020 Evox Therapeutics Appoints Paul Carter as Non-Executive Chairman 14th May 2020 Evox Therapeutics and Takeda sign multi-target rare disease collaboration 26th Mar 2020 Pagination Go to page 1Go to page 2Go to page 3
Evox Therapeutics expands existing exosome patent portfolio with further grant covering exosomes for RNA therapeutics 15th Jul 2020
Evox Therapeutics announces a multi-target RNA interference and antisense research collaboration and license agreement with Lilly 9th Jun 2020